Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

8.490
+0.1601.92%
Volume:110.99M
Turnover:947.98M
Market Cap:97.82B
PE:23.03
High:8.720
Open:8.460
Low:8.300
Close:8.330
52wk High:11.454
52wk Low:4.463
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.36
T/O Rate:0.96%
Dividend:0.24
Dividend Rate:2.82%
EPS(LYR):0.369
ROE:10.83%
ROA:5.65%
PB:2.60
PE(LYR):23.03
PS:3.29

Loading ...

CSPC Pharmaceutical Group Limited (1093) Announces U.S. FDA Approval for Clinical Trials

Bulletin Express
·
Mar 02

CSPC PHARMA's Novel Albumin-Bound Paclitaxel Injection Receives FDA Clearance for US Clinical Trials

Stock News
·
Mar 02

CSPC Paclitaxel Albumin-Bound Formulation Wins FDA Clinical Trial Approval in U.S

Reuters
·
Mar 02

CSPC Pharmaceutical - Approval From U.S. Food and Drug Administration

THOMSON REUTERS
·
Mar 02

CSPC Pharmaceutical - Paclitaxel Protein-Bound Particles for Injectable Suspension, Rapid Suspension (Albumin-Bound) (Syhx2011g1)

THOMSON REUTERS
·
Mar 02

CSPC PHARMA Appoints Zhang Yiwei as Executive Director

Stock News
·
Mar 02

CSPC Pharmaceutical Group Files List of Directors With HKEX

Reuters
·
Mar 02

BRIEF-CSPC Pharmaceutical Appoints Zhang Yiwei As Executive Director

Reuters
·
Mar 02

CSPC Pharmaceutical Appoints Zhang Yiwei as Executive Director

Reuters
·
Mar 02

CSPC Pharmaceutical Group Stock Sheds 3.2% in Hong Kong

Dow Jones
·
Mar 02

UBS Forecasts 10% Revenue Growth for Healthcare Sector This Year, Names 3SBIO as Top Pick

Stock News
·
Mar 02

CSPC Pharmaceutical Group (SEHK:1093) Valuation Check After New Long-Acting Obesity And Pain Drug Trial Approvals

Simply Wall St.
·
Feb 28

CSPC Pharmaceutical to Sell 30% Stake in Guoxin Huijin for 230 Million Yuan

MT Newswires Live
·
Feb 27

CSPC Pharmaceutical Group (1093) Announces Disposal of 30.07% Stake in Beijing Guoxin Huijin for RMB230.00 million

Bulletin Express
·
Feb 26

CSPC PHARMA Subsidiary to Divest 30.07% Stake in Beijing Guoxin Huijin

Stock News
·
Feb 26

CSPC Pharmaceutical - Expects to Record Loss on Disposal Attributable RMB15 Mln

THOMSON REUTERS
·
Feb 26

CSPC Pharmaceutical - Disposal of 30.0704% Equity Interest in Target Company

THOMSON REUTERS
·
Feb 26

CSPC Pharmaceutical - Consideration of RMB230 Mln

THOMSON REUTERS
·
Feb 26

CSPC Pharmaceutical Group Stock Falls 4.5% in Hong Kong

Dow Jones
·
Feb 26

CSPC Pharma Retains "Outperform" Rating with HK$13.07 Target from Haitong International

Stock News
·
Feb 25